Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

Cancer Patients Have No Generic Options. Everything Must Be Branded. Offered Through a Cancer Center. After 40 Years in Practice, the Suspicion Is Now Intentional Suppression. Ivermectin and mebendazole — cheap, widely available, showing 84% clinical benefit in cancer patients — are not offered through a single cancer center...

McCulloughFund's profile picture

McCullough Foundation

77,423 subscribers

14,426 Aufrufe • vor 25 Tagen •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

What Is a Turbo Cancer? A Cardiologist With 40 Years of Practice Says He's Never Seen Anything Like It. Younger patients. More aggressive at presentation. Progressing faster than anything in the textbooks. A bladder cancer so rapidly growing an entire organ had to be removed. Colon cancer now the leading cancer in men under 45. Turbo cancer isn't a fringe term — it's a clinical observation being documented across practices nationwide, and the pattern is new. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom
1:04

What Is a Turbo Cancer? A Cardiologist With 40 Years of Practice Says He's Never Seen Anything Like It. Younger patients. More aggressive at presentation. Progressing faster than anything in the textbooks. A bladder cancer so rapidly growing an entire organ had to be removed. Colon cancer now the leading cancer in men under 45. Turbo cancer isn't a fringe term — it's a clinical observation being documented across practices nationwide, and the pattern is new. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom

McCullough Foundation

18,463 Aufrufe • vor 3 Monaten

Patterns in Cancer That Have Never Been Seen Before. Time Magazine Put It on the Cover. Nobody Connected the Dots. Multiple cancer types in a single patient. Colon cancer rising in men under 45. Cancers appearing at younger ages, progressing faster, presenting more severely. Time Magazine described the phenomenon without naming a cause. The clinical data pointing to a post-pandemic origin has been in the peer-reviewed literature for two years. The mainstream press still won't say it. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom
1:33

Patterns in Cancer That Have Never Been Seen Before. Time Magazine Put It on the Cover. Nobody Connected the Dots. Multiple cancer types in a single patient. Colon cancer rising in men under 45. Cancers appearing at younger ages, progressing faster, presenting more severely. Time Magazine described the phenomenon without naming a cause. The clinical data pointing to a post-pandemic origin has been in the peer-reviewed literature for two years. The mainstream press still won't say it. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom

McCullough Foundation

27,141 Aufrufe • vor 3 Monaten

COVID Taught Us One Thing Above All: We Cannot Blindly Trust the Government or the Medical Establishment to Do Right By Us. The biopharmaceutical complex — what some call the biomedical deep state — is oriented against the patient's best interests when affordable, safe generics can solve the problem. Ivermectin and mebendazole were suppressed during COVID. The same compounds now show 84% clinical benefit in cancer patients. People who asked questions got banned on TikTok. Got shadowbanned. Got fired. The Declaration of Independence guarantees bodily autonomy. The pandemic was a direct assault on it. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom
1:33

COVID Taught Us One Thing Above All: We Cannot Blindly Trust the Government or the Medical Establishment to Do Right By Us. The biopharmaceutical complex — what some call the biomedical deep state — is oriented against the patient's best interests when affordable, safe generics can solve the problem. Ivermectin and mebendazole were suppressed during COVID. The same compounds now show 84% clinical benefit in cancer patients. People who asked questions got banned on TikTok. Got shadowbanned. Got fired. The Declaration of Independence guarantees bodily autonomy. The pandemic was a direct assault on it. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom

McCullough Foundation

16,460 Aufrufe • vor 25 Tagen

Ivermectin + Mebendazole: The Cancer Study That Changes the Conversation. Two anti-infective drugs. Both already FDA-approved. Both already widely available. Together they reduce cancer cell proliferation, cut off the tumor's blood supply, and trigger cancer cell self-termination. 84% net clinical benefit across prostate, breast, and lung cancer patients. The National Cancer Institute needs to move on this now. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), American Sunrise #MedicalFreedom
1:50

Ivermectin + Mebendazole: The Cancer Study That Changes the Conversation. Two anti-infective drugs. Both already FDA-approved. Both already widely available. Together they reduce cancer cell proliferation, cut off the tumor's blood supply, and trigger cancer cell self-termination. 84% net clinical benefit across prostate, breast, and lung cancer patients. The National Cancer Institute needs to move on this now. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), American Sunrise #MedicalFreedom

McCullough Foundation

15,826 Aufrufe • vor 3 Monaten

JAMA Reported That Ivermectin and Mebendazole Use in Cancer Patients Has Skyrocketed. The NCI Has Been Watching. Now They Need to Act. A report from Rockwell and colleagues in JAMA confirms what patient data has been showing for over a year — use of ivermectin and mebendazole among cancer patients surged through 2025. Mel Gibson's appearance on Joe Rogan accelerated it further. The first clinical report shows 84% positive impact — cancers held stable or improved when the combination was added to traditional care. The National Cancer Institute is tracking this. The next step is a large prospective randomized double-blind placebo-controlled trial. The data is there. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise John Solomon Amanda Head #MedicalFreedom
0:54

JAMA Reported That Ivermectin and Mebendazole Use in Cancer Patients Has Skyrocketed. The NCI Has Been Watching. Now They Need to Act. A report from Rockwell and colleagues in JAMA confirms what patient data has been showing for over a year — use of ivermectin and mebendazole among cancer patients surged through 2025. Mel Gibson's appearance on Joe Rogan accelerated it further. The first clinical report shows 84% positive impact — cancers held stable or improved when the combination was added to traditional care. The National Cancer Institute is tracking this. The next step is a large prospective randomized double-blind placebo-controlled trial. The data is there. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise John Solomon Amanda Head #MedicalFreedom

McCullough Foundation

20,224 Aufrufe • vor 1 Monat

Ivermectin and Mebendazole Cost a Fraction of Chemo. Big Pharma Can't Patent Them. That's the Problem. Cancer centers get a cut of every chemotherapy bill. Generic drugs don't generate that margin. Two affordable, widely available compounds showing 84% clinical benefit in a real-world cancer cohort still don't have a single large-scale randomized trial behind them — not because the science isn't there, but because the incentive structure isn't. The National Cancer Institute needs to run the trial. The patients can't keep waiting. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Steve Gruber Daybreak, The Steve Gruber Show Steve Gruber #MedicalFreedom
1:13

Ivermectin and Mebendazole Cost a Fraction of Chemo. Big Pharma Can't Patent Them. That's the Problem. Cancer centers get a cut of every chemotherapy bill. Generic drugs don't generate that margin. Two affordable, widely available compounds showing 84% clinical benefit in a real-world cancer cohort still don't have a single large-scale randomized trial behind them — not because the science isn't there, but because the incentive structure isn't. The National Cancer Institute needs to run the trial. The patients can't keep waiting. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Steve Gruber Daybreak, The Steve Gruber Show Steve Gruber #MedicalFreedom

McCullough Foundation

33,132 Aufrufe • vor 3 Monaten

Cancer Breakthrough: Two Cheap Generic Drugs. One Stunning Combination. Ivermectin and mebendazole — both FDA-approved, both widely available, both dirt cheap — are showing results in solid organ cancers that expensive chemotherapy protocols can't match on safety alone. Large-scale randomized trials are the next step. The data is already there to justify them. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
1:36

Cancer Breakthrough: Two Cheap Generic Drugs. One Stunning Combination. Ivermectin and mebendazole — both FDA-approved, both widely available, both dirt cheap — are showing results in solid organ cancers that expensive chemotherapy protocols can't match on safety alone. Large-scale randomized trials are the next step. The data is already there to justify them. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

22,830 Aufrufe • vor 3 Monaten

A Cancer Study With 84% Positive Results. The NIH Should Have Done This. Nearly 200 patients. Prostate. Breast. Lung. Solid organ cancers — many already metastatic. 48% reported regression. 36% held stable. The combination is widely available, inexpensive, and now under peer review. The National Cancer Institute still hasn't moved. The question is why. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
1:39

A Cancer Study With 84% Positive Results. The NIH Should Have Done This. Nearly 200 patients. Prostate. Breast. Lung. Solid organ cancers — many already metastatic. 48% reported regression. 36% held stable. The combination is widely available, inexpensive, and now under peer review. The National Cancer Institute still hasn't moved. The question is why. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

40,752 Aufrufe • vor 3 Monaten

Ivermectin + Mebendazole Is Outperforming Cancer Treatments Nobody Can Afford. 48% reported actual tumor regression. 36% held stable. Only 15% worsened — in a population of nearly 200 solid organ cancer patients, many already widely metastatic. These are preliminary patient-reported outcomes. They are also the most encouraging cancer data most people haven't heard about. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon #MedicalFreedom
1:27

Ivermectin + Mebendazole Is Outperforming Cancer Treatments Nobody Can Afford. 48% reported actual tumor regression. 36% held stable. Only 15% worsened — in a population of nearly 200 solid organ cancer patients, many already widely metastatic. These are preliminary patient-reported outcomes. They are also the most encouraging cancer data most people haven't heard about. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon #MedicalFreedom

McCullough Foundation

24,006 Aufrufe • vor 3 Monaten

Generic Drugs With Decades of Safety Data. Promising Early Results. Still No Large Trials. That Needs to Change Now. Ivermectin. Mebendazole. Repurposed compounds with established safety profiles and mounting evidence of efficacy — in cancer, in infection, in chronic disease. The pipeline for large-scale trials exists. The incentive structure doesn't support it. RFK and the National Cancer Institute have an opportunity to fast-track what Big Pharma won't touch. The data is ready. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon, Amanda Head Amanda Head #MedicalFreedom
0:35

Generic Drugs With Decades of Safety Data. Promising Early Results. Still No Large Trials. That Needs to Change Now. Ivermectin. Mebendazole. Repurposed compounds with established safety profiles and mounting evidence of efficacy — in cancer, in infection, in chronic disease. The pipeline for large-scale trials exists. The incentive structure doesn't support it. RFK and the National Cancer Institute have an opportunity to fast-track what Big Pharma won't touch. The data is ready. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon, Amanda Head Amanda Head #MedicalFreedom

McCullough Foundation

11,283 Aufrufe • vor 3 Monaten

JAMA Reported That Ivermectin and Mebendazole Use in Cancer Patients Has Skyrocketed. The NCI Has Been Watching. Now They Need to Act. A report from Rockwell and colleagues in JAMA confirms what patient data has been showing for over a year - use of ivermectin and mebendazole among cancer patients surged through 2025. Mel Gibson's appearance on Joe Rogan accelerated it further. The first clinical report shows 84% positive impact - cancers held stable or improved when the combination was added to traditional care. The National Cancer Institute is tracking this. The next step is a large prospective randomized double-blind placebo-controlled trial. The data is there. The patients can't wait. #ivermectin #mebendazole #cancercure
0:54

JAMA Reported That Ivermectin and Mebendazole Use in Cancer Patients Has Skyrocketed. The NCI Has Been Watching. Now They Need to Act. A report from Rockwell and colleagues in JAMA confirms what patient data has been showing for over a year - use of ivermectin and mebendazole among cancer patients surged through 2025. Mel Gibson's appearance on Joe Rogan accelerated it further. The first clinical report shows 84% positive impact - cancers held stable or improved when the combination was added to traditional care. The National Cancer Institute is tracking this. The next step is a large prospective randomized double-blind placebo-controlled trial. The data is there. The patients can't wait. #ivermectin #mebendazole #cancercure

Dr. Alejandro Martínez-Ruiz 🇺🇸🇲🇽

20,072 Aufrufe • vor 19 Tagen

Cancer Cells and Parasites Feed the Same Way. That's Why This Drug Combination Works. Both drain energy from the host using similar biological mechanisms. Ivermectin and mebendazole — developed to fight parasites — disrupt that process in cancer cells too. They reduce proliferation, cut off the blood supply tumors try to build, and accelerate the packaging and termination of cancer cells. Over 100 pre-clinical studies confirm it. The human data just confirmed it at scale. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), The Steve Gruber Show Steve Gruber #MedicalFreedom
0:54

Cancer Cells and Parasites Feed the Same Way. That's Why This Drug Combination Works. Both drain energy from the host using similar biological mechanisms. Ivermectin and mebendazole — developed to fight parasites — disrupt that process in cancer cells too. They reduce proliferation, cut off the blood supply tumors try to build, and accelerate the packaging and termination of cancer cells. Over 100 pre-clinical studies confirm it. The human data just confirmed it at scale. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), The Steve Gruber Show Steve Gruber #MedicalFreedom

McCullough Foundation

15,960 Aufrufe • vor 3 Monaten

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure
3:49

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Dr. Zakaria MD

46,602 Aufrufe • vor 19 Tagen

197 Cancer Patients. 84% Reported Clinical Benefit. The Results Are In — And They're Encouraging. Prostate. Breast. Lung. Solid organ cancers across the board — nearly 200 patients tracked for six months on off-label ivermectin and mebendazole. About half saw cancer disappear or regress. A third held stable. The study is conditionally accepted in a peer-reviewed journal. Large-scale randomized trials are the next step. The data says start them now. Join the Fight: Courtesy of The Amber May Show Catch the full episode: #MedicalFreedom
1:17

197 Cancer Patients. 84% Reported Clinical Benefit. The Results Are In — And They're Encouraging. Prostate. Breast. Lung. Solid organ cancers across the board — nearly 200 patients tracked for six months on off-label ivermectin and mebendazole. About half saw cancer disappear or regress. A third held stable. The study is conditionally accepted in a peer-reviewed journal. Large-scale randomized trials are the next step. The data says start them now. Join the Fight: Courtesy of The Amber May Show Catch the full episode: #MedicalFreedom

McCullough Foundation

17,960 Aufrufe • vor 2 Monaten

Even the Minority Witness at Ron Johnson's Cancer Senate Hearings Had to Agree: COVID Vaccines Appear to Be Causing Cancer in Some People. Breast. Female reproductive. Colon cancer in women. Prostate. Lung. Colorectal in men. Cancer has been rising for two decades — but the curves have now taken a hockey stick upward inflection. The Senate hearing brought UK and US cancer experts together, and the conclusion was not disputed across party lines. Screen now. Re-screen. Total body MRI technology exists. We need to be ahead of this — because too many people are already at risk. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
0:53

Even the Minority Witness at Ron Johnson's Cancer Senate Hearings Had to Agree: COVID Vaccines Appear to Be Causing Cancer in Some People. Breast. Female reproductive. Colon cancer in women. Prostate. Lung. Colorectal in men. Cancer has been rising for two decades — but the curves have now taken a hockey stick upward inflection. The Senate hearing brought UK and US cancer experts together, and the conclusion was not disputed across party lines. Screen now. Re-screen. Total body MRI technology exists. We need to be ahead of this — because too many people are already at risk. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

15,144 Aufrufe • vor 23 Tagen

Social Media Knew About Ivermectin and Cancer Before the Institutions Did. That Should Embarrass Them. Patients were already talking about it. Requesting it. Using it. A private company tracked the outcomes because no major research body would. Now Johns Hopkins and Cedars-UCLA are finally running protocols. The conversation started in the places they told you not to trust. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
1:11

Social Media Knew About Ivermectin and Cancer Before the Institutions Did. That Should Embarrass Them. Patients were already talking about it. Requesting it. Using it. A private company tracked the outcomes because no major research body would. Now Johns Hopkins and Cedars-UCLA are finally running protocols. The conversation started in the places they told you not to trust. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

29,220 Aufrufe • vor 3 Monaten

5,800 New Cancer Cases Every Day. One in Three Americans Will Be Diagnosed. And a Treatment Nobody Is Talking About. 2,114,000 projected new cancer diagnoses in 2026. 20 million Americans currently living with cancer. 40% of us will die from it. Meanwhile, a Nobel Prize-winning compound with over 100 pre-clinical studies showing anti-cancer mechanisms just posted an 84% clinical benefit rate in a real-world patient cohort — and the cancer centers are incentivized to ignore it. Join the Fight: Courtesy of The Lance Wallnau Show Lance Wallnau #MedicalFreedom
1:12

5,800 New Cancer Cases Every Day. One in Three Americans Will Be Diagnosed. And a Treatment Nobody Is Talking About. 2,114,000 projected new cancer diagnoses in 2026. 20 million Americans currently living with cancer. 40% of us will die from it. Meanwhile, a Nobel Prize-winning compound with over 100 pre-clinical studies showing anti-cancer mechanisms just posted an 84% clinical benefit rate in a real-world patient cohort — and the cancer centers are incentivized to ignore it. Join the Fight: Courtesy of The Lance Wallnau Show Lance Wallnau #MedicalFreedom

McCullough Foundation

22,974 Aufrufe • vor 3 Monaten

The COVID Infection Alone — Without the Vaccine — May Have Already Increased Cancer Risk. The Vaccine Made It Worse. And Cancer Research Is Still Ignoring Both. The spike protein from the Wuhan lab-origin virus suppresses P53 and BRCA tumor surveillance systems. Infection loads it into the body. The vaccine loads in more. Research stratifying cancer outcomes by vaccination status, number of doses, product type, and number of COVID infections does not yet exist at scale. Companies aren't doing it. The NCI isn't funding it. Senator Ron Johnson's hearings are forcing the conversation. The data is being ignored — and that choice has a body count. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
0:44

The COVID Infection Alone — Without the Vaccine — May Have Already Increased Cancer Risk. The Vaccine Made It Worse. And Cancer Research Is Still Ignoring Both. The spike protein from the Wuhan lab-origin virus suppresses P53 and BRCA tumor surveillance systems. Infection loads it into the body. The vaccine loads in more. Research stratifying cancer outcomes by vaccination status, number of doses, product type, and number of COVID infections does not yet exist at scale. Companies aren't doing it. The NCI isn't funding it. Senator Ron Johnson's hearings are forcing the conversation. The data is being ignored — and that choice has a body count. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

12,453 Aufrufe • vor 23 Tagen

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."
1:59

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."

Sense Receptor

227,993 Aufrufe • vor 8 Monaten

A Tick Bite Can Give You Lyme. Rocky Mountain Spotted Fever. Babesiosis. And an Enzyme That Makes You Permanently Allergic to Red Meat. It's called alpha-gal syndrome — and it's not rare anymore. The tick injects enzymes along with its saliva that sensitize the immune system to a sugar molecule found in mammalian meat. Six to nine months later, a burger sends you to the ER. Wear long sleeves in the brush. Remove the tick including the head. Clean the site. And take doxycycline immediately — within 72 hours of removal. One dose can spare a lifetime of Lyme disease misery. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom
0:56

A Tick Bite Can Give You Lyme. Rocky Mountain Spotted Fever. Babesiosis. And an Enzyme That Makes You Permanently Allergic to Red Meat. It's called alpha-gal syndrome — and it's not rare anymore. The tick injects enzymes along with its saliva that sensitize the immune system to a sugar molecule found in mammalian meat. Six to nine months later, a burger sends you to the ER. Wear long sleeves in the brush. Remove the tick including the head. Clean the site. And take doxycycline immediately — within 72 hours of removal. One dose can spare a lifetime of Lyme disease misery. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom

McCullough Foundation

24,500 Aufrufe • vor 25 Tagen